(19)
(11) EP 1 019 502 A2

(12)

(88) Date of publication A3:
15.04.1999

(43) Date of publication:
19.07.2000 Bulletin 2000/29

(21) Application number: 98939199.0

(22) Date of filing: 04.08.1998
(51) International Patent Classification (IPC)7C12N 15/12, C07K 14/705, C07K 16/28, C12N 15/62, C12N 15/63, C12P 21/08, A61K 38/16
(86) International application number:
PCT/US9816/202
(87) International publication number:
WO 9907/738 (18.02.1999 Gazette 1999/07)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 06.08.1997 US 54869 P

(71) Applicants:
  • REGENERON PHARMACEUTICALS, INC.
    Tarrytown, NY 10591-6707 (US)
  • THE PROCTER & GAMBLE COMPANY
    Cincinnati,Ohio 45202 (US)

(72) Inventors:
  • MASIAKOWSKI, Piotr, J.
    Pleasant Valley, NY 12569 (US)
  • MORRIS, Jodi
    New City, NY 10956 (US)
  • VALENZUELA, David, M.
    Yorktown Heights, NY 10598 (US)

(74) Representative: Goldin, Douglas Michael 
J.A. KEMP & CO.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) HUMAN ORPHAN RECEPTOR NTR-1